These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11757558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2003 Jun 24; 68(121):37411-4. PubMed ID: 12836650
    [Abstract] [Full Text] [Related]

  • 4. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2002 Mar 28; 67(60):14853-62. PubMed ID: 11922057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2006 Sep 26; 71(186):56008-27. PubMed ID: 17017470
    [Abstract] [Full Text] [Related]

  • 9. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2011 Dec 01; 76(231):74696-9. PubMed ID: 22145189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
    Fed Regist; 1999 May 13; 64(92):25910-2. PubMed ID: 10558537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medicaid program; time limitation on record keeping requirements under the drug rebate program. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2004 Jan 06; 69(3):508-14. PubMed ID: 14968795
    [Abstract] [Full Text] [Related]

  • 14. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2010 Jun 29; 75(124):37301-7. PubMed ID: 20608286
    [Abstract] [Full Text] [Related]

  • 15. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2002 Aug 09; 67(154):51987-52007. PubMed ID: 12194173
    [Abstract] [Full Text] [Related]

  • 16. Registration and reregistration application fees. Final rule; remanded for further notice and comment.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 1996 Dec 30; 61(251):68624-6. PubMed ID: 12192680
    [Abstract] [Full Text] [Related]

  • 17. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
    Drug Enforcement Administration (DEA), U.S. Department of Justice.
    Fed Regist; 2007 Apr 23; 72(77):20039-47. PubMed ID: 17520757
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2017 Jul 14; 82(134):32457-61. PubMed ID: 28715162
    [Abstract] [Full Text] [Related]

  • 20. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2008 May 22; 73(100):29685-8. PubMed ID: 18605404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.